Fig. 3: Factors associated with HBV reactivation after vaccination.

Factors associated with HBV reactivation after vaccination for (a) all HSCT patients with or without cessation of immunosuppressant, (b) allogeneic HSCT patients with or without cessation of immunosuppressant, (c) all HSCT patients with anti-HBs titer <10 mIU/mL or >10 mIU/mL at baseline, and (d) allogeneic HSCT patients with anti-HBs titer <10 mIU/mL or >10 mIU/mL at baseline. Risk factors associated with HBV reactivation after vaccination were evaluated using the Fine and Gray model for univariate analysis. We defined censor for any reasons as competing risk. P values < 0.05 were considered to be statistically significant.